SUCNR1 and obesity disorder: Succinate and its receptor SUCNR1 exacerbate this obesity-induced inflammation, promoting the infiltration of macrophages into adipose tissue, which is a key contributor to the glucose intolerance observed in type 2 diabetes (21).